Category: Static

Connecticut hospital's neuroscience center gets $430M facelift

The topping out of a $430 million two-tower Neurosciences Center project is being celebrated at Yale New Haven (Conn.) Health. 

Good news for frequently downgraded Buffalo health system

Buffalo, N.Y.-based Catholic Health has received a Moody’s Investors Service upgrade following a string of downgrades over the last two years, Buffalo Business First reported Dec. 1.

HHS urges healthcare orgs to nix vulnerability

The HHS is urging healthcare organizations to patch a new vulnerability affecting NetScaler ADC, formerly Citrix ADC, and NetScaler Gateway. 

Corewell Health caught in MOVEit breach

Patient information may have been compromised at Corewell Health as the communications software company the organization uses was hit by the massive MOVEit breach that affected companies around the U.S.

Lawmakers probe FDA's decongestant decision

House Republicans are investigating the FDA’s regulation of a common decongestant found in over-the-counter cold medicines that the agency recently determined to be ineffective, The Hill reported Dec. 4. 

A busy week of mergers and acquisitions

The last week of November was a busy one for hospital and health system mergers and acquisitions. 

Connecticut approves labor, delivery closure at Hartford HealthCare hospital

Windham (Conn.) Hospital, part of Hartford (Conn.) HealthCare, received approval from the state to end its labor and delivery services after a three-year process, the Connecticut Mirror reported Dec. 1.

California lawmaker warns of 'unintended consequences' of healthcare worker minimum wage

A California lawmaker is speaking out about what she says are “unintended consequences” for hospitals related to a new law that will gradually raise healthcare workers’ hourly minimum wage to $25.

Boston Children's taps primary care leadership

Margaret Fry, MD, was selected as the next president and CEO of the Pediatric Physicians’ Organization at Boston Children’s Hospital. 

Eli Lilly drug gets new approval for blood cancer

The FDA has granted approval to Eli Lilly and Company’s drug Jaypirca, a therapy to treat chronic lymphocytic leukemia or small lymphocytic lymphoma.